UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older

The New England journal of medicine, 2017-06, Vol.376 (25), p.2427-2436

2017

Volltextzugriff (PDF)

Recombinant protein vaccines produced in insect cells

Vaccine, 2012-02, Vol.30 (10), p.1759-1766

Cox, Manon M.J

2012

Volltextzugriff (PDF)

Formal to informal learning with IT: research challenges and issues for e-learning

Journal of computer assisted learning, 2013-02, Vol.29 (1), p.85-105

Cox, M.J.

2013

Volltextzugriff (PDF)

Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant

Vaccine, 2012-08, Vol.30 (36), p.5407-5416

2012

Volltextzugriff (PDF)

Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process

Vaccine, 2014-09, Vol.32 (42), p.5496-5502

2014

Volltextzugriff (PDF)

Development and Validation of a Hopkinson Bar for Hazardous Materials

Experimental mechanics, 2020-11, Vol.60 (9), p.1275-1288

2020

Volltextzugriff (PDF)

FluBlok, a next generation influenza vaccine manufactured in insect cells

Biologicals, 2009-06, Vol.37 (3), p.182-189

2009

Volltextzugriff (PDF)

The effect of impurity inclusions on the pitting corrosion behaviour of beryllium

Corrosion science, 2010-08, Vol.52 (8), p.2535-2546

2010

Volltextzugriff (PDF)

Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine

Vaccine, 2006-03, Vol.24 (12), p.2176-2185

2006

Volltextzugriff (PDF)

FluBlok, a recombinant hemagglutinin influenza vaccine

Influenza and other respiratory viruses, 2008-11, Vol.2 (6), p.211-219

2008

Volltextzugriff (PDF)

A fast track influenza virus vaccine produced in insect cells

Journal of invertebrate pathology, 2011-07, Vol.107, p.S31-S41

2011

Volltextzugriff (PDF)

Randomized comparison of the safety of Flublok® versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥50 years of age

Vaccine, 2015-11, Vol.33 (48), p.6622-6628

2015

Volltextzugriff (PDF)

Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells

Biotechnology and bioengineering, 2015-11, Vol.112 (11), p.2267-2275

2015

Volltextzugriff (PDF)

Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate

Vaccine, 2015-11, Vol.33 (44), p.6011-6016

2015

Volltextzugriff (PDF)

An experimental methodology to characterise post-necking behaviour and quantify ductile damage accumulation in isotropic materials

International journal of solids and structures, 2019-11, Vol.176-177, p.191-206

2019

Volltextzugriff (PDF)

Vaccine Technology V: The art of taking vaccines to disease prevention

Vaccine, 2015-08, Vol.33 (35), p.4219-4220

2015

Volltextzugriff (PDF)

Uniaxial compression of single crystal and polycrystalline tantalum

Materials science & engineering. A, Structural materials : properties, microstructure and processing, 2019-06, Vol.759, p.70-77

2019

Volltextzugriff (PDF)

Plant species responses along a grazing disturbance gradient in Australian grassland

Journal of vegetation science, 1999-02, Vol.10 (1), p.77-86

1999

Volltextzugriff (PDF)

Innovations in vaccine development: can regulatory authorities keep up?

Expert review of vaccines, 2012-10, Vol.11 (10), p.1171-1173

2012

Volltextzugriff (PDF)

Immunotherapy: TNFR2 AS A TARGET TO IMPROVE CD19-DIRECTED CART CELL FITNESS AND ANTITUMOR ACTIVITY IN LARGE B CELL LYMPHOMA

Cytotherapy (Oxford, England), 2022-05, Vol.24 (5), p.S36-S37

2022

Volltextzugriff (PDF)

WS19-5 Bacterial and fungal microbiota associated with fungal disease in cystic fibrosis and bronchiectasis

Journal of cystic fibrosis, 2019-06, Vol.18, p.S36-S36

2019

Volltextzugriff (PDF)

GM-CSF disruption in cart cells ameliorates cart cell activation and reduces activation-induced cell death

Cytotherapy (Oxford, England), 2021-05, Vol.23 (5), p.S29-S30

2021

Volltextzugriff (PDF)

Innovations in the Insect Cell Expression System for Industrial Recombinant Vaccine Antigen Production

Vaccines (Basel), 2021-12, Vol.9 (12), p.1504

Cox, Manon M J

2021

Volltextzugriff (PDF)

Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18–49 Years of Age

The Journal of infectious diseases, 2017-12, Vol.216 (10), p.1219-1226

2017

Volltextzugriff (PDF)

University students' attainment and perceptions of computer delivered assessment; a comparison between computer-based and traditional tests in a ‘high-stakes’ examination: Student online assessment

Journal of computer assisted learning, 2011-10, Vol.27 (5), p.440-447

2011

Volltextzugriff (PDF)

1 – 25 von 423

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(378)
Mit Volltextzugriff
(381)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(423)
Japanisch
(50)

Erscheinungsjahr

n.n

Thema

Science & Technology
(250)
Life Sciences & Biomedicine
(159)
Humans
(97)
Physical Sciences
(67)
Physics
(60)
Animals
(59)
Biological And Medical Sciences
(54)
Female
(53)
Male
(49)
Technology
(47)
Medical Sciences
(29)
Fundamental And Applied Biological Sciences. Psychology
(27)
Adult
(26)
Aged
(23)
Engineering
(22)
Experiment
(22)
Middle Aged
(22)
Particle Physics
(22)
Biochemistry & Molecular Biology
(19)
Influenza
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older

Recombinant protein vaccines produced in insect cells

Formal to informal learning with IT: research challenges and issues for e-learning

Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant

Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process

Development and Validation of a Hopkinson Bar for Hazardous Materials

FluBlok, a next generation influenza vaccine manufactured in insect cells

The effect of impurity inclusions on the pitting corrosion behaviour of beryllium

Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine

FluBlok, a recombinant hemagglutinin influenza vaccine

A fast track influenza virus vaccine produced in insect cells

Randomized comparison of the safety of Flublok® versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥50 years of age

Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells

Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate

An experimental methodology to characterise post-necking behaviour and quantify ductile damage accumulation in isotropic materials

Vaccine Technology V: The art of taking vaccines to disease prevention

Uniaxial compression of single crystal and polycrystalline tantalum

Plant species responses along a grazing disturbance gradient in Australian grassland

Innovations in vaccine development: can regulatory authorities keep up?

Immunotherapy: TNFR2 AS A TARGET TO IMPROVE CD19-DIRECTED CART CELL FITNESS AND ANTITUMOR ACTIVITY IN LARGE B CELL LYMPHOMA

WS19-5 Bacterial and fungal microbiota associated with fungal disease in cystic fibrosis and bronchiectasis

GM-CSF disruption in cart cells ameliorates cart cell activation and reduces activation-induced cell death

Innovations in the Insect Cell Expression System for Industrial Recombinant Vaccine Antigen Production

Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18–49 Years of Age

University students' attainment and perceptions of computer delivered assessment; a comparison between computer-based and traditional tests in a ‘high-stakes’ examination: Student online assessment

Suchergebnisse filtern